Loading...

Zynerba Pharmaceuticals, Inc.

0M40.L•LSE
Healthcare
Medical - Pharmaceuticals
£1.30
£0.03(2.76%)

Zynerba Pharmaceuticals, Inc. (0M40.L) Stock Overview

Explore Zynerba Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 61.9/100

Key Financials

Market Cap49M
P/E Ratio-1.59
EPS (TTM)$-0.96
ROE-0.59%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$0.16

0M40.L Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Zynerba Pharmaceuticals, Inc. (0M40.L) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.16.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.59 and a market capitalization of 49M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
2.76%
3-Month Change
278.92%
6-Month Change
266.16%
Year-to-Date (YTD) Change
118.08%
1-Year Change
104.55%
3-Year Change
-61.67%
5-Year Change
-76.89%
All-Time (Max) Change
-89.19%

Contact Information

https://www.zynerba.com
484 581 7505
80 West Lancaster Avenue, Devon, PA, 19333

Company Facts

25 Employees
IPO DateJan 29, 2018
CountryUS

Frequently Asked Questions

;